KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Medpace Holdings (MEDP) Depreciation & Amortization (CF) (2016 - 2025)

Medpace Holdings (MEDP) has disclosed Depreciation & Amortization (CF) for 10 consecutive years, with $6.9 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Depreciation & Amortization (CF) fell 3.4% year-over-year to $6.9 million, compared with a TTM value of $27.2 million through Dec 2025, down 2.24%, and an annual FY2025 reading of $27.2 million, down 2.24% over the prior year.
  • Depreciation & Amortization (CF) was $6.9 million for Q4 2025 at Medpace Holdings, up from $6.8 million in the prior quarter.
  • Across five years, Depreciation & Amortization (CF) topped out at $7.2 million in Q3 2024 and bottomed at $3.8 million in Q1 2021.
  • Average Depreciation & Amortization (CF) over 5 years is $5.7 million, with a median of $6.1 million recorded in 2023.
  • The sharpest move saw Depreciation & Amortization (CF) skyrocketed 55.4% in 2021, then decreased 4.82% in 2025.
  • Year by year, Depreciation & Amortization (CF) stood at $4.2 million in 2021, then grew by 21.17% to $5.1 million in 2022, then increased by 26.62% to $6.4 million in 2023, then rose by 11.13% to $7.1 million in 2024, then decreased by 3.4% to $6.9 million in 2025.
  • Business Quant data shows Depreciation & Amortization (CF) for MEDP at $6.9 million in Q4 2025, $6.8 million in Q3 2025, and $6.8 million in Q2 2025.